AGP Picks
View all

French Polynesia Business Press
Provided by AGP

French Polynesia Business Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Polynesia Business Press.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 3, 2026

Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Sep. 3, 2026

Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Sep. 3, 2026

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Victoria’s Secret & Co. Reports Second Quarter 2026 Results
Sep. 3, 2026

Victoria’s Secret & Co. Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Sep. 3, 2026

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Real Matters Announces Departure of Chief Financial Officer
Sep. 3, 2026

Real Matters Announces Departure of Chief Financial Officer

Indeterminate GlobeNewswire
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting
Sep. 3, 2026

C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting

Indeterminate GlobeNewswire
Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
Sep. 3, 2026

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference

Indeterminate GlobeNewswire
Alternative Ballistics Appoints Sertan Ayçiçek to Help Drive Global Expansion, Strategic Investment and Commercial Growth
Sep. 3, 2026

Alternative Ballistics Appoints Sertan Ayçiçek to Help Drive Global Expansion, Strategic Investment and Commercial Growth

Indeterminate GlobeNewswire
EdgeMode secures FINRA completion of Form 211 review, permitting sponsoring market maker to initiate quotations
Sep. 3, 2026

EdgeMode secures FINRA completion of Form 211 review, permitting sponsoring market maker to initiate quotations

Indeterminate GlobeNewswire
Commercial Collection Agency Vetting: Seven Questions, One Formal Standard
Sep. 3, 2026

Commercial Collection Agency Vetting: Seven Questions, One Formal Standard

Indeterminate GlobeNewswire
Stallion Completes Ground Gravity, Identifies Three New Priority Target Areas At Stone Island
Sep. 3, 2026

Stallion Completes Ground Gravity, Identifies Three New Priority Target Areas At Stone Island

Indeterminate GlobeNewswire
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Sep. 3, 2026

Gyre Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire
JPMorgan ETFs (Ireland) ICAV: Dividend Declaration
Sep. 3, 2026

JPMorgan ETFs (Ireland) ICAV: Dividend Declaration

Indeterminate GlobeNewswire
ANI Pharmaceuticals to Present at September Investor Conferences
Sep. 3, 2026

ANI Pharmaceuticals to Present at September Investor Conferences

Indeterminate GlobeNewswire
ScottsMiracle-Gro to Acquire Black Kow in Alignment with SMG 2.0 Growth Strategy
Sep. 3, 2026

ScottsMiracle-Gro to Acquire Black Kow in Alignment with SMG 2.0 Growth Strategy

Indeterminate GlobeNewswire
Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026
Sep. 3, 2026

Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026

Indeterminate GlobeNewswire
Virtune AB (Publ) (“Virtune”) has completed the monthly rebalancing for September 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
Sep. 3, 2026

Virtune AB (Publ) (“Virtune”) has completed the monthly rebalancing for September 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics

Indeterminate GlobeNewswire
Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för september 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP
Sep. 3, 2026

Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för september 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP

Indeterminate GlobeNewswire
Lands’ End Announces Second Quarter Fiscal 2026 Results
Sep. 3, 2026

Lands’ End Announces Second Quarter Fiscal 2026 Results

Indeterminate GlobeNewswire
Scorpio Tankers Inc. Announces Updates on Third Quarter 2026 TCE Rates and Time Charter-Out Agreements
Sep. 3, 2026

Scorpio Tankers Inc. Announces Updates on Third Quarter 2026 TCE Rates and Time Charter-Out Agreements

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

French Polynesia Business Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.